Evidence map›Paper›PMID 30860678›Full record

ArticleJournal of biomedical materials research. Part B, Applied biomaterials2019

Photopolymerizable gelatin and hyaluronic acid for stereolithographic 3D bioprinting of tissue-engineered cartilage.

Tobias Lam, Tilo Dehne, Jan Philipp Krüger, Sylvia Hondke, Michaela Endres, Alexander Thomas, Roland Lauster, Michael Sittinger, Lutz Kloke

Open access · hybridAbstract read
In one paragraph

Article in Journal of biomedical materials research. Part B, Applied biomaterials, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 1 pooled it
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 1 synthesis or guideline pooled it, 187 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Branding a New Technological Outlook for Future Orthopaedics.Bioengineering (Basel, Switzerland) · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Tobias LamCellbricks GmbH, Berlin, Germany.ORCID 0000-0003-1404-7822
Tilo DehneCharité - Universitätsmedizin Berlin, Department of Rheumatology and Clinical Immunology, Laboratory for Tissue Engineering.
Jan Philipp KrügerTransTissue Technologies GmbH, Berlin, Germany.
Sylvia HondkeTransTissue Technologies GmbH, Berlin, Germany.ORCID 0000-0001-7742-5128
Michaela EndresTransTissue Technologies GmbH, Berlin, Germany.
Alexander ThomasCellbricks GmbH, Berlin, Germany.
Roland LausterTechnische Universität Berlin, Institute of Medical Biotechnology, Berlin, Germany.
Michael SittingerCharité - Universitätsmedizin Berlin, Department of Rheumatology and Clinical Immunology, Laboratory for Tissue Engineering.
Lutz KlokeCellbricks GmbH, Berlin, Germany.
TransTissue (Germany) · DECharité - Universitätsmedizin Berlin · DETechnische Universität Berlin · DE

Funding

Bundesministerium für Bildung und Forschung 13GW0099Bundesministerium für Wirtschaft und Energie 03EFEBE077
6 · The paper itself

Abstract

To create artificial cartilage in vitro, mimicking the function of native extracellular matrix (ECM) and morphological cartilage-like shape is essential. The interplay of cell patterning and matrix concentration has high impact on the phenotype and viability of the printed cells. To advance the capabilities of cartilage bioprinting, we investigated different ECMs to create an in vitro chondrocyte niche. Therefore, we used methacrylated gelatin (GelMA) and methacrylated hyaluronic acid (HAMA) in a stereolithographic bioprinting approach. Both materials have been shown to support cartilage ECM formation and recovery of chondrocyte phenotype. We used these materials as bioinks to create cartilage models with varying chondrocyte densities. The models maintained shape, viability, and homogenous cell distribution over 14 days in culture. Chondrogenic differentiation was demonstrated by cartilage-typical proteoglycan and type II collagen deposition and gene expression (COL2A1, ACAN) after 14 days of culture. The differentiation pattern was influenced by cell density. A high cell density print (25 × 10

Indexed as

BioprintingPhotochemical ProcessesPrinting, Three-DimensionalAnimalsCartilageChondrocytesGelatinHyaluronic AcidMaterials TestingSwineTissue EngineeringTissue ScaffoldsGelatinHyaluronic Acidarticular cartilagebiomaterialbioprintinggelatinhyaluronic acidphotopatterningstereolithographytissue engineering

Identifiers

PMID30860678
PMCPMC6790697
OpenAlexW2921525840

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.